BG-C0902
/ BeOne Medicines
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
December 04, 2025
A First-in-Human Study of BG-C0902 Alone and in Combination With Other Therapeutic Agents in Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=63 | Recruiting | Sponsor: BeiGene | Not yet recruiting ➔ Recruiting
Enrollment open • First-in-human • Oncology • Solid Tumor
September 19, 2025
A First-in-Human Study of BG-C0902 Alone and in Combination With Other Therapeutic Agents in Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=63 | Not yet recruiting | Sponsor: BeiGene
First-in-human • New P1 trial • Oncology • Solid Tumor
1 to 2
Of
2
Go to page
1